SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CORALLINI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.155
AS - Asia 1.611
EU - Europa 817
SA - Sud America 228
AF - Africa 28
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.846
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.098
SG - Singapore 666
CN - Cina 541
BR - Brasile 201
UA - Ucraina 188
DE - Germania 157
GB - Regno Unito 133
IT - Italia 126
HK - Hong Kong 125
TR - Turchia 118
VN - Vietnam 75
FI - Finlandia 57
SE - Svezia 39
CA - Canada 38
RU - Federazione Russa 33
PL - Polonia 22
IN - India 19
FR - Francia 17
ZA - Sudafrica 17
AR - Argentina 16
MX - Messico 14
CZ - Repubblica Ceca 10
IQ - Iraq 9
BD - Bangladesh 8
ES - Italia 8
ID - Indonesia 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
AU - Australia 5
BE - Belgio 5
IR - Iran 5
JP - Giappone 5
NL - Olanda 5
PK - Pakistan 5
UZ - Uzbekistan 5
IL - Israele 4
CO - Colombia 3
EC - Ecuador 3
EG - Egitto 3
NP - Nepal 3
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
HN - Honduras 1
IE - Irlanda 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 6.846
Salva come PNG Salva come JPEG
Città #
Fairfield 505
Woodbridge 470
Ashburn 391
Singapore 337
Houston 269
Seattle 223
Ann Arbor 221
Chandler 211
Jacksonville 209
Cambridge 183
Wilmington 166
Beijing 159
Santa Clara 150
Hong Kong 125
Los Angeles 83
New York 79
Dallas 77
Nanjing 69
Izmir 66
Princeton 47
Munich 36
San Diego 35
Boardman 34
Ho Chi Minh City 32
Milan 31
Shanghai 26
Shenyang 25
Nanchang 23
São Paulo 23
Ferrara 21
Buffalo 20
Warsaw 18
Tianjin 15
Changsha 14
Falls Church 13
Jinan 13
Montreal 13
San Mateo 13
The Dalles 13
Hanoi 12
Johannesburg 12
Turku 12
Auburn Hills 11
Hebei 11
London 11
Mountain View 11
Poplar 11
Zhengzhou 11
Chennai 10
Chicago 10
Frankfurt am Main 10
Mexico City 10
Orem 10
San Francisco 10
Dearborn 9
Hefei 9
Falkenstein 8
Stockholm 8
Atlanta 7
Bremen 7
Brno 7
Philadelphia 7
Toronto 7
Boston 6
Brasília 6
Brooklyn 6
Columbus 6
Haikou 6
Manchester 6
Moscow 6
Ottawa 6
Redwood City 6
Rome 6
Brussels 5
Charlotte 5
Denver 5
Kunming 5
Norwalk 5
Porto Alegre 5
Tappahannock 5
Tokyo 5
Ardabil 4
Curitiba 4
Guarulhos 4
Haiphong 4
Hangzhou 4
Leawood 4
Phoenix 4
Rio de Janeiro 4
Tashkent 4
Vancouver 4
Ankara 3
Augusta 3
Bologna 3
Changchun 3
Da Nang 3
Des Moines 3
Guangzhou 3
Helsinki 3
Jakarta 3
Totale 4.856
Salva come PNG Salva come JPEG
Nome #
Antiangiogenic activity of the MDM2 antagonist nutlin-3 218
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 210
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 207
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 206
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies 196
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 195
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 191
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 189
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 186
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 183
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 181
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 177
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 174
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 170
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 170
Potential role of PKC inhibitors in the treatment of hematological malignancies 163
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 160
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 156
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 153
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 152
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 151
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 147
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 145
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 144
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 143
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 134
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 134
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 129
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 125
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 120
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 120
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 118
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 105
null 102
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 98
null 97
null 94
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 93
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 93
null 90
null 89
null 88
null 86
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 85
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 84
null 78
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 74
null 74
null 65
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 58
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 47
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 36
Totale 6.883
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.717
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 56 15 73 16 68 75 30
2021/2022522 15 57 56 11 15 26 35 25 14 29 66 173
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/2025988 21 32 66 50 144 72 23 47 216 75 143 99
2025/20261.561 281 99 287 344 394 156 0 0 0 0 0 0
Totale 6.883